X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1664) 1664
Publication (167) 167
Book / eBook (34) 34
Conference Proceeding (25) 25
Magazine Article (17) 17
Book Chapter (11) 11
Dissertation (8) 8
Newspaper Article (8) 8
Book Review (7) 7
Patent (3) 3
Trade Publication Article (2) 2
Journal / eJournal (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (587) 587
microbiology (396) 396
index medicus (391) 391
infectious diseases (329) 329
microbial sensitivity tests (318) 318
anti-bacterial agents - pharmacology (302) 302
pharmacology & pharmacy (228) 228
female (158) 158
male (157) 157
surgery (149) 149
infectious disease (133) 133
adult (114) 114
middle aged (104) 104
infections (103) 103
resistance (103) 103
dentistry (97) 97
dentistry, oral surgery & medicine (95) 95
surveillance (95) 95
drug resistance, bacterial (91) 91
susceptibility (88) 88
cephalosporins - pharmacology (83) 83
united states (78) 78
analysis (76) 76
gram-positive bacteria - drug effects (76) 76
adolescent (73) 73
animals (73) 73
gram-negative bacteria - drug effects (71) 71
internal medicine (71) 71
aged (69) 69
hospitals (61) 61
biochemical phenomena, metabolism, and nutrition (60) 60
united-states (58) 58
staphylococcus aureus - drug effects (57) 57
europe (56) 56
pneumonia (56) 56
epidemiology (55) 55
resistant staphylococcus-aureus (55) 55
gram-positive bacterial infections - microbiology (54) 54
health aspects (53) 53
pathogens (53) 53
antimicrobial resistance (52) 52
drug resistance, multiple, bacterial (49) 49
in-vitro activity (49) 49
microbial sensitivity tests - methods (49) 49
bacterial infections and mycoses (48) 48
enterobacteriaceae - drug effects (47) 47
mrsa (47) 47
staphylococcus aureus (47) 47
enterobacteriaceae (46) 46
pseudomonas aeruginosa - drug effects (46) 46
research (45) 45
vancomycin (44) 44
oncology (42) 42
physics, applied (42) 42
population surveillance (41) 41
streptococcus pneumoniae - drug effects (41) 41
cross infection - microbiology (40) 40
epidemiology and surveillance (40) 40
gram-negative bacteria - isolation & purification (40) 40
gram-positive bacteria - isolation & purification (40) 40
treatment outcome (40) 40
bacterial pneumonia (39) 39
child (39) 39
staphylococcus-aureus (39) 39
bacteremia (38) 38
bacteria (38) 38
in-vitro (38) 38
bacteria - drug effects (36) 36
latin america (35) 35
streptococcus-pneumoniae (35) 35
daptomycin - pharmacology (34) 34
engineering, biomedical (34) 34
staphylococcal infections - microbiology (34) 34
staphylococcus - drug effects (34) 34
drug resistance in microorganisms (32) 32
medicine & public health (32) 32
methicillin-resistant staphylococcus aureus - drug effects (32) 32
drug resistance, microbial (31) 31
biomedical materials (30) 30
management (30) 30
sensitivity and specificity (30) 30
spectrum (30) 30
streptococcus - drug effects (30) 30
anti-bacterial agents - therapeutic use (29) 29
community-acquired infections - microbiology (29) 29
mechanics (29) 29
retrospective studies (29) 29
united states - epidemiology (29) 29
young adult (29) 29
antimicrobial activity (28) 28
drug resistance (28) 28
pseudomonas-aeruginosa (28) 28
vancomycin - pharmacology (28) 28
bone (27) 27
efficacy (27) 27
gram-negative bacterial infections - microbiology (27) 27
latin america - epidemiology (27) 27
north america (27) 27
prevalence (27) 27
pseudomonas aeruginosa (27) 27
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (13) 13
Robarts - Stacks (9) 9
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Faculty of Information - Stacks (1) 1
OISE - Curriculum Resources (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Reference (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1570) 1570
Portuguese (89) 89
German (79) 79
French (18) 18
Spanish (13) 13
Arabic (1) 1
Persian (1) 1
Romanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article